(Q39408655)

11 September 2017

title

Dab2 is pivotal for endothelial cell migration by mediating VEGF expression in cancer cells (English)

1 reference

11 September 2017

0 references

1 reference

4

Yong Song Gho

1 reference

11 September 2017

Seong-Moon Cheong

1

1 reference

11 September 2017

Hyemin Choi

series ordinal

2

1 reference

11 September 2017

Bok Sil Hong

series ordinal

3

1 reference

11 September 2017

Jin-Kwan Han

series ordinal

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

14 January 2012

1 reference

Experimental Cell Research

11 September 2017

published in

1 reference

11 September 2017

volume

318

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

550-557

1 reference

Vascular endothelial growth factor is a secreted angiogenic mitogen

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Angiogenesis as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Signaling by members of the TGF-beta family in vascular morphogenesis and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor‐β induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen‐activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Down-Regulation of DOC-2 in Colorectal Cancer Points to Its Role as a Tumor Suppressor in This Malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Hematopoietic gene expression profile in zebrafish kidney marrow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Xenopus Dab2 is required for embryonic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Morphogenesis of human endothelial cells is inhibited by DAB2 via Src

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Hypoxia--a key regulatory factor in tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

Angiogenesis: an organizing principle for drug discovery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.01.013

10.1016/J.YEXCR.2012.01.013

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference